Company Overview and News

 
Even with headwinds, home builder stocks are ‘ludicrously cheap,’ these analysts say

2018-10-19 marketwatch
A ‘don’t fight the Fed’ mentality has kept some investors away from builder stocks, but the millennial American dream may be a stronger force
HHC

 
October 19 Research Roundup: Dementia, Frankenstein Proteins, and Epigenetic Sperm Changes

2018-10-19 biospace
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
HHC

14
Boeing's new business targets computers modelled on human brains

2018-10-19 nzherald.co.nz
Boeing Co. is creating a new unit to focus on technology that's seemingly straight out of science fiction, including super-fast computing that mimics the synapses of the human brain and hack-proof communications links based on applied quantum physics.
HHC BOE GM HRS BA

14
Boeing creates unit to focus on super-computing that mimics the brain, hack-proof communications

2018-10-18 japantimes.co.jp
CHICAGO – Boeing Co. is creating a new unit to focus on technology that’s seemingly straight out of science fiction, including super-fast computing that mimics the synapses of the human brain and hack-proof communications links based on applied quantum physics.
HHC BOE GM HRS BA

1
REFILE-OBITUARY-Microsoft co-founder Paul Allen dies of cancer at 65

2018-10-16 reuters
Oct 15 (Reuters) - Microsoft Corp co-founder Paul Allen, the man who persuaded school-friend Bill Gates to drop out of Harvard to start what became the world’s biggest software company, died on Monday at the age of 65, his family said.
HHC CHTR MSFT

1
Microsoft co-founder Paul Allen dies of cancer complications at 65

2018-10-16 channelnewsasia
REUTERS: Microsoft Corp co-founder Paul Allen, the man who persuaded school-friend Bill Gates to drop out of Harvard to start what became the world's biggest software company, died on Monday at the age of 65, his family said.
HHC CHTR MSFT

1
Microsoft co-founder Paul Allen dies of cancer complications at 65

2018-10-15 reuters
(Reuters) - Microsoft Corp (MSFT.O) co-founder Paul Allen, the man who persuaded school-friend Bill Gates to drop out of Harvard to start what became the world’s biggest software company, died on Monday at the age of 65, his family said.
HHC CHTR MSFT

1
OBITUARY-Microsoft co-founder Paul Allen dies of cancer at 65

2018-10-15 reuters
Oct 15 (Reuters) - Microsoft Corp co-founder Paul Allen, the man who persuaded school-friend Bill Gates to drop out of Harvard to start what became the world’s biggest software company, died on Monday at the age of 65, his family said.
HHC CHTR MSFT

1
Microsoft co-founder Paul Allen dies of cancer at 65

2018-10-15 reuters
(Reuters) - Microsoft Corp (MSFT.O) co-founder Paul Allen, the man who persuaded school-friend Bill Gates to drop out of Harvard to start what became the world’s biggest software company, died on Monday at the age of 65, his family said.
HHC CHTR MSFT

3
Chris Mayer Interview: World According to Boyar Podcast

2018-09-28 marketfolly
Boyar Value Group recently started doing a podcast entitled The World According to Boyar. In it, they'll conversations with top investors, authors, and businesspeople. Their first guest was Chris Mayer, author of How Do You Know as well as the investing book: 100 Baggers. He is the Chief Investment Strategist of Bonner & Partners. Here's some notes from the podcast as well as the full podcast audio embedded below: Chris Mayer Interview on Boyar Podcast - On 100 Baggers, it's basically taking the concept of a 10x return on a stock from Peter Lynch and adding a zero to it, to find the cream of the crop in terms of investment returns.
BRK.A HHC

 
Consolidated Communications Expands Fiber Network and Broadband Services to Willis, Texas

2018-09-24 globenewswire
Residents now have access to 1 Gig Internet Speeds, competitive broadband services Businesses to benefit from wide range of fiber-based communication solutions
CNSL HHC

 
1
HHC / Howard Hughes Corp. (The) / Pershing Square Capital Management, L.P. - SC 13D/A (Activist Investment)

2018-09-19 sec.gov - 1
SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
HHC

1
HHC / Howard Hughes Corp. (The) / Pershing Square Capital Management, L.P. - SC 13D/A (Activist Investment)

2018-09-19 sec.gov - 1
SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
HHC

8
The Howard Hughes Buys Two Office Buildings in The Woodlands

2018-09-06 zacks
The Howard Hughes Corporation (HHC - Free Report) recently announced the acquisition of two Class-A office buildings in the 28,000-acre master-planned community of The Woodlands. The acquisition deal also includes excess land where The Howard Hughes has scope to build another office building. The purchase was made in an off-market transaction for $53 million. The vacant four- and six-story buildings comprise 257,025 square feet of rentable space and are located next to the company’s Hughes Landing Development.
SWX HHC CBG GPN KHC CIG CIGI CBRE

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to HHC / Howard Hughes Corp. (The) on message board site Silicon Investor.

PHHC - Phoenix Healthcare Corporation PHHC - Phoenix Healthcare Corporation PHHC - Phoenix Healthcare Corporation IHHC - International Healthcare Holdings Inc IHHC - International Healthcare Holdings Inc IHHC - International Healthcare Holdings Inc
HHCA. Home Health Corp of America HHCA. Home Health Corp of America HHCA. Home Health Corp of America
CUSIP: 44267D107